Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
Andrea Delli PizziRoberta CianciDomenico GenovesiGianluigi EspositoMauro TimpaniAlessandra TavolettaPierluigi PulsoneRaffaella BasilicoDaniela GabrielliConsuelo RosaLuciana CaravattaMonica Di TommasoMassimo CauloAntonella FilipponePublished in: Abdominal radiology (New York) (2019)
ΔADC at 2 weeks after the beginning of CRT is a reliable tool to early assess treatment response.
Keyphrases
- rectal cancer
- locally advanced
- diffusion weighted
- contrast enhanced
- magnetic resonance imaging
- neoadjuvant chemotherapy
- squamous cell carcinoma
- phase ii study
- radiation therapy
- computed tomography
- diffusion weighted imaging
- patients undergoing
- magnetic resonance
- stem cells
- heart failure
- left ventricular
- lymph node
- mesenchymal stem cells
- cardiac resynchronization therapy
- gestational age
- atrial fibrillation
- preterm birth